Literature DB >> 15710499

Quil A-lipid powder formulations releasing ISCOMs and related colloidal structures upon hydration.

Patrick H Demana1, Nigel M Davies, Sarah Hook, Thomas Rades.   

Abstract

The aim of the present study was to prepare solid Quil A-cholesterol-phospholipid formulations (as powder mixtures or compressed to pellets) by physical mixing or by freeze-drying of aqueous dispersions of these components in ratios that allow spontaneous formation of ISCOMs and other colloidal structures upon hydration. The effect of addition of excess cholesterol to the lipid mixtures on the release of a model antigen (PE-FITC-OVA) from the pellets was also investigated. Physical properties were evaluated by X-ray powder diffractometry (XPRD), differential scanning calorimetry (DSC), scanning electron microscopy (SEM), and polarized light microscopy (PLM). Characterization of aqueous colloidal dispersions was performed by negative staining transmission electron microscopy (TEM). Physically mixed powders (with or without PE-FITC-OVA) and pellets prepared from the same powders did not spontaneously form ISCOM matrices and related colloidal structures such as worm-like micelles, ring-like micelles, lipidic/layered structures and lamellae (hexagonal array of ring-like micelles) upon hydration as expected from the pseudo-ternary diagram for aqueous mixtures of Quil A, cholesterol and phospholipid. In contrast, spontaneous formation of the expected colloids was demonstrated for the freeze-dried lipid mixtures. Pellets prepared by compression of freeze-dried powders released PE-FITC-OVA slower than those prepared from physically mixed powders. TEM investigations revealed that the antigen was released in the form of colloidal particles (ISCOMs) from pellets prepared by compression of freeze-dried powders. The addition of excess cholesterol slowed down the release of antigen. The findings obtained in this study are important for the formulation of solid Quil A-containing lipid articles as controlled particulate adjuvant containing antigen delivery systems.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15710499     DOI: 10.1016/j.jconrel.2004.11.027

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  4 in total

1.  RBD decorated PLA nanoparticle admixture with aluminum hydroxide elicit robust and long lasting immune response against SARS-CoV-2.

Authors:  Jairam Meena; Priyank Singhvi; Sudeepa Srichandan; Jyotsna Dandotiya; Juhi Verma; Mamta Singh; Rahul Ahuja; Neha Panwar; Tabiya Qayoom Wani; Ritika Khatri; Gazala Siddiqui; Anuradha Gupta; Sweety Samal; Amulya Kumar Panda
Journal:  Eur J Pharm Biopharm       Date:  2022-05-17       Impact factor: 5.589

2.  Co-Administration of Lipid Nanoparticles and Sub-Unit Vaccine Antigens Is Required for Increase in Antigen-Specific Immune Responses in Mice.

Authors:  Elizabeth A Thoryk; Gokul Swaminathan; Steven Meschino; Kara S Cox; Marian Gindy; Danilo R Casimiro; Andrew J Bett
Journal:  Vaccines (Basel)       Date:  2016-12-06

3.  Enhanced immunization via dissolving microneedle array-based delivery system incorporating subunit vaccine and saponin adjuvant.

Authors:  Ji-Hui Zhao; Qi-Bo Zhang; Bao Liu; Xiang-Hua Piao; Yu-Lu Yan; Xiao-Ge Hu; Kuan Zhou; Yong-Tai Zhang; Nian-Ping Feng
Journal:  Int J Nanomedicine       Date:  2017-07-04

4.  Next-Generation COVID-19 Vaccines Should Take Efficiency of Distribution into Consideration.

Authors:  Khaled AboulFotouh; Zhengrong Cui; Robert O Williams
Journal:  AAPS PharmSciTech       Date:  2021-04-09       Impact factor: 3.246

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.